Cartilage Cells, also known as chondrocytes, are the primary cellular components of cartilage, a specialized connective tissue that provides structural support and flexibility to various parts of the body. Distributed within the extracellular matrix of cartilage, chondrocytes play a fundamental role in maintaining tissue integrity and function. These cells are responsible for the synthesis and maintenance of the extracellular matrix, which consists of collagen, proteoglycans, and other molecules crucial for cartilage's unique properties. Chondrocytes are well-adapted to their avascular environment, relying on diffusion for nutrient supply and waste removal. Their remarkable ability to balance matrix synthesis and degradation contributes to cartilage's resilience and resistance to compression. While chondrocytes are essential for cartilage homeostasis, their limited proliferative capacity poses challenges for cartilage repair and regeneration. Advances in regenerative medicine explore strategies like tissue engineering and stem cell therapies to enhance the regenerative potential of cartilage cells, offering hope for improved treatments for conditions such as osteoarthritis and cartilage injuries. Understanding the biology and behavior of cartilage cells is integral to unlocking new therapeutic avenues and improving the overall management of cartilage-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy